119 HR 6321 IH: Lung Cancer Medicare Access to Precise Testing Act U.S. House of Representatives 2025-11-28 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I119th CONGRESS1st SessionH. R. 6321IN THE HOUSE OF REPRESENTATIVESNovember 28, 2025Mr. Gottheimer (for himself and Mrs. Kiggans of Virginia) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concernedA BILLTo amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.

1.

Short title

This Act may be cited as the Lung Cancer Medicare Access to Precise Testing Act.

2.

Requiring coverage of lung cancer biomarker testing under Medicare

(a)

Coverage

Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended— (1)in subsection (s)(2)— (A)in subparagraph (JJ), by adding and at the end; and (B)by adding at the end the following new subparagraph: (KK)lung cancer biomarker testing (as defined in subsection (nnn));; and (2)by adding at the end the following new subsection: (nnn)

Lung cancer biomarker testing

The term lung cancer biomarker testing means a test furnished on or after January 1, 2027, to an individual diagnosed with lung cancer for the identification of 1 or more specific biomarkers (such as genes, proteins, or other molecules) based on the analysis of such individual’s tissue, blood, or bodily fluids.. (b)

Payment

Section 1833(a)(1) of the Social Security Act (42 U.S.C. 1395y(a)(1)) is amended— (1)by striking and (HH) and inserting (HH); and (2)by inserting , and (II) with respect to lung cancer biomarker testing (as defined in section 1861(nnn)), the amount paid shall be 100 percent of the reasonable charges for such testing before the semicolon at the end.